ATAD3A and hepatocellular carcinoma: ATAD3A was reported to be upregulated in certain types of cancer, including hepatocellular carcinoma (HCC), head and neck squamous cell carcinoma (HNSCC), and lung adenocarcinoma [29,58,59,60].